PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
6.26%
Revenue growth above 1.5x MU's 1.29%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
5.32%
Gross profit growth above 1.5x MU's 3.11%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
5.90%
Positive EBIT growth while MU is negative. John Neff might see a substantial edge in operational management.
6.24%
Positive operating income growth while MU is negative. John Neff might view this as a competitive edge in operations.
4.09%
Positive net income growth while MU is negative. John Neff might see a big relative performance advantage.
4.20%
Positive EPS growth while MU is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
3.81%
Positive diluted EPS growth while MU is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.33%
Share reduction while MU is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.43%
Reduced diluted shares while MU is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.04%
Dividend growth of 0.04% while MU is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-17.54%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-31.16%
Negative FCF growth while MU is at 51.11%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
93.65%
10Y revenue/share CAGR under 50% of MU's 230.83%. Michael Burry would suspect a lasting competitive disadvantage.
52.48%
5Y revenue/share CAGR at 75-90% of MU's 64.52%. Bill Ackman would encourage strategies to match competitor’s pace.
44.72%
3Y revenue/share CAGR 1.25-1.5x MU's 32.84%. Bruce Berkowitz might see better product or regional expansions than the competitor.
224.56%
10Y OCF/share CAGR under 50% of MU's 455.12%. Michael Burry would worry about a persistent underperformance in cash creation.
108.31%
5Y OCF/share CAGR at 50-75% of MU's 153.61%. Martin Whitman would question if the firm lags in monetizing revenue effectively.
0.26%
3Y OCF/share CAGR under 50% of MU's 5.15%. Michael Burry would worry about a significant short-term disadvantage in generating operational cash.
536.51%
Net income/share CAGR at 50-75% of MU's 987.30%. Martin Whitman might question if the firm’s product or cost base lags behind.
134.40%
5Y net income/share CAGR similar to MU's 148.61%. Walter Schloss might see both on parallel mid-term trajectories.
78.80%
3Y net income/share CAGR above 1.5x MU's 39.15%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
56.50%
Below 50% of MU's 422.40%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
42.19%
Below 50% of MU's 228.90%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
69.13%
3Y equity/share CAGR above 1.5x MU's 37.79%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
573.58%
Dividend/share CAGR of 573.58% while MU is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
129.97%
Dividend/share CAGR of 129.97% while MU is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
49.53%
3Y dividend/share CAGR of 49.53% while MU is zero. Bruce Berkowitz sees a minor positive difference that could attract dividend-focused investors.
22.01%
AR growth well above MU's 2.55%. Michael Burry fears inflated revenue or higher default risk in the near future.
6.75%
Inventory growth well above MU's 11.52%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.19%
Negative asset growth while MU invests at 4.00%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.86%
Under 50% of MU's 4.22%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-6.43%
We’re deleveraging while MU stands at 0.87%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
5.88%
R&D growth drastically higher vs. MU's 11.24%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
No Data
No Data available this quarter, please select a different quarter.